Concord Biotech Limited - Company Profile

It is a chemicals public limited company based in Ahmedabad, Gujarat, India, established in 1984.
1984 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Concord Biotech Limited

Concord Biotech Limited, a active public limited company, was established on 23 November 1984 in Ahmedabad, Gujarat, India. Engaging in chemical products within the manufacturing sector, it holds CIN: L24230GJ1984PLC007440. Registered under ROC Roc Ahmedabad. it is listed. It has an authorized capital of ₹11.00 Cr and a paid-up capital of ₹10.46 Cr.

Formerly known as Servomed Pharmaceuticals Private Limited, Servomed Pharmaceuticals Limited. It upholds a compliant status. In 2023, it reported revenue of ₹888.48 Cr and a net worth of ₹1,291.98 Cr. Employing 1,516 professional, Its leadership includes Arvind Motilal Agarwal (Director), Rajiv Ambrish Agarwal (Director), Bharti Khanna (Director). Past directors included Harcharan Singh, Om Dutt Tyagi, Yasir Yusufali Rawjee. It holds ₹45.00 Cr open charges and ₹154.77 Cr settled loans. Its latest AGM occurred on 09 September 2025, with the balance sheet filed on 31 March 2025. It is based at 1482-86 Trasad Road Dholka, Ahmedabad, Gujarat, 387810.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L24230GJ1984PLC007440

  • Registration Number

    007440

  • Incorporation Date

    23 November 1984

  • Authorized Capital

    ₹11.00 Cr

  • Paid-Up Capital

    ₹10.46 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Listed

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 11.00 Cr
  • Paid Up Capital ₹ 10.46 Cr
  • Company Age 41 Year, 3 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 45.00 Cr
  • Satisfied Charges ₹ 154.77 Cr
  • Revenue Growth **** 20.66%
  • Profit Growth **** 33.35%
  • Ebitda **** 25.62%
  • Net Worth 16.69%
  • Total Assets **** 15.32%
Company report

Concord Biotech Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Concord Biotech Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Concord Biotech Limited?
Current Directors
Name Designation Appointment Date Status
Arvind Motilal Agarwal Director 24 May 2022 Current
Rajiv Ambrish Agarwal Director 30 Jun 2008 Current
Bharti Khanna Director 31 Jan 2017 Current
Amitabh Gajendra Thakore Director 31 Jan 2017 Current
Chakravarthy Sriraman Mandayam Director 14 Jun 2022 Current
Ravi Kapoor Director 15 Dec 2003 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 05 Jul 2016 Past
Pramod Abcsdd Director 21 Dec 2007 Past
Pramod Abcsdd Director 04 Dec 2009 Past
Pramod Abcsdd Additional Director 08 Jul 2022 Past
Pramod Abcsdd Additional Director 30 Sep 2009 Past
Pramod Abcsdd Director 04 Dec 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Concord Biotech.

Concord Biotech Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.66% increase. The company also saw a substantial improvement in profitability, with a 33.35% increase in profit. The company's net worth Soared by an impressive increase of 16.69%.

Concord Biotech revenue growth over time
Concord Biotech profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 20.66%
*******
*******
*******
*******
Revenue from Operations
*******
 19.67%
*******
*******
*******
*******
Total Assets
*******
 15.32%
*******
*******
*******
*******
Profit or Loss
*******
 33.35%
*******
*******
*******
*******
Net Worth
*******
 16.69%
*******
*******
*******
*******
EBITDA
*******
 25.62%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Concord Biotech?

In 2023, Concord Biotech had a promoter holding of 29.40% and a public holding of 70.60%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹450,000,000.00

Satisfied Charges

₹1,547,675,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 45.00 Cr
Latest Charge Details
Date Lender Amount Status
27 Jan 2003 Axis Bank Limited ₹45.00 Cr Open
17 Oct 2019 State Bank Of India ₹110.00 Cr Satisfied
11 Aug 2015 Citi Bank N.A. ₹30.82 Cr Satisfied
09 Dec 2014 Citi Bank N.A. ₹10.00 Cr Satisfied
23 Jan 2012 Citibank N. A. ₹3.70 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Concord Biotech?

Concord Biotech has a workforce of 1516 employees as of Apr 14, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Concord Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Concord Biotech's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Concord Biotech
Recent Activity within the Organization
  • Director Appointment

    Progress on Ravirajbhai Ghanshyambhai Karia was appointed as a CFO was appointed as a CFO on 18 Dec 2025 & has been associated with this company since 3 months 2 days . was documented.

  • Annual General Meeting

    The activity Concord Biotech Limited last Annual general meeting of members was held on 09 Sep 2025 as per latest MCA records. was completed.

  • Charges

    The activity A charge registered on 17 Oct 2019 via Charge ID 100298054 with State Bank Of India was fully satisfied on 29 May 2025. was completed.

  • Balance Sheet

    The activity Concord Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.

  • Charges

    Progress on A charge with Axis Bank Limited of Rs. 45.00 Cr registered on 27 Jan 2003 with Charge ID 90099613 was modified on 31 Jul 2023. was documented.

  • Director Appointment

    Progress on Chakravarthy Sriraman Mandayam was appointed as a Director was appointed as a Director on 14 Jun 2022 & has been associated with this company since 3 years 9 months . was documented.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Concord Biotech Limited?

The CIN of Concord Biotech Limited is L24230GJ1984PLC007440.

Where is Concord Biotech Limited headquartered?

Concord Biotech Limited is headquartered at 1482-86 Trasad Road Dholka, Ahmedabad, Gujarat, 387810.

When was Concord Biotech Limited incorporated?

Concord Biotech Limited was incorporated on 23 November 1984.

Who are the current directors of Concord Biotech Limited?

The current directors of Concord Biotech Limited are

What is the primary industry of Concord Biotech Limited?

The primary industry of Concord Biotech Limited is Manufacturing.

Is Concord Biotech Limited a listed company?

Concord Biotech Limited is listed.

What is the capital structure of Concord Biotech Limited?

The authorized capital of Concord Biotech Limited is ₹11.00 Cr, and the paid-up capital is ₹10.46 Cr.

What is the compliance status of Concord Biotech Limited?

The compliance status of Concord Biotech Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available